TABLE 2

Summary of PK parameters after single-dose intravenous administration of PSArFVIII presentations or rFVIII to FVIII KO mice

Values in parentheses refer to two-sided 95% confidence intervals; n = 6/group/time point.

ParameterrFVIII (200 IU/kg)
PSAylation Degree: 5.4PSAylation Degree: 10.4PSAylation Degree: 13.3PSAylation Degree: 16.4PSAylation Degree: 0
mol/molmol/molmol/molmol/molmol/mol
Tmax (min)55555
Cmax (IU/ml)4.33 (3.89–4.76)2.92 (1.83–4.01)3.70 (2.90–4.51)4.22 (3.82–4.63)2.40 (1.14–3.66)
IR (IU/ml)/(IU/kg)0.0143 (0.0129–0.0158)0.0146 (0.0092–0.0201)0.0176 (0.0138–0.0214)0.0154 (0.0139–0.0169)0.0101 (0.0048–0.0154)
Terminal half-life (h)7.37 (1.54–13.20)6.51 (5.19–7.82)5.14 (4.65–5.63)7.38 (6.55–8.20)3.20 (2.71–3.70)
AUC0–40 h (IU/ml⋅h)27.19 (22.53–31.85)21.06 (18.24–23.89)18.86 (17.22–20.50)26.64 (24.54–28.74)6.872 (5.711–8.034)
AUC0–∞ (IU/ml⋅h)27.69 (23.34–32.04)21.35 (18.48–24.23)18.94 (17.28–20.6)27.25 (25.0–29.5)6.87 (5.71–8.04)
MRT (h)8.97 (7.56–10.37)9.06 (7.85–10.27)7.21 (6.59–7.83)10.22 (9.17–11.27)4.18 (3.57–4.78)
CL (ml/h per kilogram)10.93 (9.21–12.64)9.34 (8.1–10.6)11.11 (10.14–12.09)10.05 (9.23–10.88)34.7 (26.83–40.57)
Vdss (ml/kg)97.96 (78.22–117.7)84.65 (71.94–97.36)80.12 (73.08–87.15)102.7 (93.20–112.3)144.9 (121.1–168.8)
  • AUC0–40 h, area under the curve from time 0 to 40 h; AUC0–∞, area under the curve from time 0 to infinity; CL, clearance; Cmax, peak plasma concentration; IR, incremental recovery; Tmax, time at Cmax; Vdss, volume of distribution at steady state.